Wave Life Sciences (NASDAQ:WVE) , developer of RNA medicines for rare genetic diseases, closed Thursday at $6.20, down 49.59% for the session. The stock sank after disappointing higher-dose WVE-007 obesity data underperformed the lower dose. Trading volume reached 49.9 million shares, coming in about 1,153% above its three-month average of 4 million shares. Wave Life Sciences IPO'd in 2015 and has fallen 61% since going public. The S&P 500 fell 1.76% to 6,476, while the Nasdaq Composite lost 2.38% to finish at 21,408. Within biotechnology , industry peers Ionis Pharmaceuticals closed at $74.24 (+2.12%) and Alnylam Pharmaceuticals ended at $328.16 (-0.16%), underscoring stock-specific trial risk for RNA-focused drug developers. Three months after Wave Life Sciences’ stock soared from $7 to $21 on positive data from positive WVE-007 weight loss data, its stock plummeted from $12 to $6 in today’s session after the company delivered an underwhelming update. While data from patients taking a 240 mg dose showed acceptable fat loss after six months, those taking a larger 400 mg dose saw results that didn’t meet the company’s expectations. Continue reading

While the stock market is facing significant volatility right now, there is a decent chance it will still perform fairly well over the next five years. That's what we have come to expect from equities, given their track record over the past decades. So, it might still be a good idea to invest in stocks right now, but not just any will do. Let's consider two healthcare companies that have the potential to perform better than broader equities through the next half a decade: Moderna (NASDAQ: MRNA) and Abivax (NASDAQ: ABVX) . Image source: Getty Images. Moderna's shares could soar as it advances its mRNA platform. Compared to older vaccines, those of the mRNA variety have advantages, including being much faster to produce and sometimes eliciting stronger, more targeted immune responses. Moderna was able to develop and market a coronavirus vaccine quickly for a reason. Now, it is going after other targets. Moderna developed a flu vaccine that is being considered for approval in the U.S. Although there are already options on the market, their efficacy generally falls between about 40% and 60% -- Moderna is looking to improve that. Continue reading

周四（3月26日）纽约尾盘，美国10年期基准国债收益率涨7.95个基点，报4.4117%，日内交投于4.3361%-4.4256%区间，整体处于上涨状态，持续走高，一度在北京时间04:11（美股收盘后不久）显著地回吐涨幅——逼近4.38%。 两年期美债收益率涨10.05个基点，报3.9858%，日内交投于3.8914%-3.9981%区间，也曾一度在美股盘后快速回吐涨幅。 20年期美债收益率涨4.85个基点，30年期美债收益率涨3.17个基点。 三年期美债收益率涨10.52个基点，五年期美债收益率涨11.45个基点，七年期美债收益率涨9.60个基点。 02/10年期美债收益率利差跌1.696个基点，报+42.382个基点。 10年期通胀保值国债（TIPS）收益率涨5.71个基点，至2.0748%；两年期TIPS收益率跌1.16个基点，至0.7123%；30年期TIPS收益率涨2.17个基点，至2.7250%。

格隆汇3月27日｜美国总统特朗普：伊朗请求给多七天时间，我给了他们十天。

美国总统特朗普26日否认急于同伊朗达成协议，并表示美国对伊朗的军事行动正在继续。早些时候，伊朗方面说，已正式回应美方所提“15点计划”，美国关于谈判的说法不过是“欺骗”伎俩。特朗普当天在内阁会议上猛烈抨击美国媒体报道他迫切期望通过外交途径结束战争，坚称是伊朗方面寻求重启谈判。他称，是否停战取决于伊朗，而在此期间，美军轰炸将继续。他还称，不在乎能否与伊朗达成协议，“我一点也不着急”。（新华社）

Bernstein downgrades QUALCOMM (QCOM) MSN

A number of stocks fell in the afternoon session as investors reacted to news of Google's new TurboQuant algorithm, a tool that threatens to significantly reduce memory requirements for artificial intelligence models.

Image source: The Motley Fool. March 26, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

中芯國際(688981)討論區- 股票評論- 股吧交流社區 Moomoo

Claire Mazumdar, Chief Executive Officer of Bicara Therapeutics Inc. (NASDAQ:BCAX) , reported the sale of 8,234 shares of Common Stock for a total of approximately $154,000 through open-market transactions from March 4, 2026 to March 6, 2026, as disclosed in the SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($18.74); post-transaction value based on March 6, 2026 market close ($18.74). *1-year price change calculated using March 26th, 2026 as the reference date. Continue reading

New York State Comptroller Thomas DiNapoli discusses the Wall Street bonus pool for 2025, attributing the rise to a surge in trading revenue. He speaks with Katie Greifeld and Bailey Lipschultz on "Bloomberg The Close." (Source: Bloomberg)

Netflix (NASDAQ:NFLX) , the global on-demand streaming and gaming platform, closed Thursday at $93.32, up 1.13%. The stock moved higher as investors reacted to fresh subscription price hikes. Investors will watch how pricing power and live-sports execution affect subscriber and revenue growth. Trading volume reached 58.3 million shares, coming in nearly 22% above its three-month average of 47.8 million shares. Netflix IPO'd in 2002 and has grown 77,901% since going public. S&P 500 (SNPINDEX:^GSPC) fell 1.74% to 6,477, while the Nasdaq Composite (NASDAQINDEX:^IXIC) lost 2.38% to finish at 21,408. Within streaming entertainment, industry players were mixed as Walt Disney (NYSE:DIS) closed at $94.75, down 1.25%, while Warner Bros. Discovery (NASDAQ:WBD) ended at $27.07, slipping 0.55%. Today, Netflix adjusted its pricing structure across all tiers, boosting subscriptions by at least $1. Its ad-supported plan moved from $7.99 to $8.99 per month while the standard and premium plans each jumped by $2 per month. The last price hike by the company took place in January 2025. Continue reading

Palantir Technologies (NASDAQ:PLTR) Trading Down 4.8% - Here's Why MarketBeat

Spotify and major record labels are seeking a $322 million default judgment from Anna's Archive, which hasn't responded to court proceedings over its scraping of millions of music files from Spotify's streaming service. The music companies are also seeking a permanent injunction in an attempt to eject the Anna's Archive website from the Internet by cutting off its access to domain and hosting providers. But the plaintiffs previously obtained a similar injunction that proved to be little more than an inconvenience for the shadow library, which has changed providers and said it's working on bolstering its ability to remain online in the face of court orders. The music companies sued Anna’s Archive in late December and quickly obtained a court order that shut down the shadow library's .org domain, though Anna's Archive has remained online elsewhere. Anna's Archive has filed no response to the lawsuit in US District Court for the Southern District of New York, and the clerk of court last month certified that the defendant is in default. Read full article Comments

tomloel The European Medicines Agency has accepted a Marketing Authorisation Application filed by Nuvation Bio ( NUVB ) and Eisai ( ESALF )( ESAIY ) for taletrectinib to treat non-small cell lung cancer. The application was given a standard review time of 210 "active" days. It is supported by data from two pivotal phase 2 studies, TRUST-I and TRUST-II. Taletrectinib is already marketed as Ibtrozi in the US and Japan. More on Nuvation Bio, Eisai Nuvation Bio Inc. (NUVB) Presents at The Citizens Life Sciences Conference 2026 Transcript Nuvation Bio Inc. (NUVB) Presents at TD Cowen 46th Annual Health Care Conference Transcript Nuvation Bio Inc. (NUVB) Q4 2025 Earnings Call Transcript Eli Lilly, Biogen/ Eisai win U.K. review for use of Alzheimer’s drugs in NHS Nuvation Bio outlines first-line IBTROZI growth strategy with 50-month median DOR amid expanding global partnerships

Taiwan Semiconductor Manufacturing (NYSE:TSM) Stock Price Down 6.3% - Time to Sell? MarketBeat

The dollar index (DXY00 ) on Thursday rose by +0.35%. The dollar rose on Thursday as doubts about whether a ceasefire in Iran will materialize weighed heavily on stocks and boosted safe-haven demand for the dollar. Also, Thursday’s decline in US weekly continuing unemployment claims to a 1.75-year low is...

【有線新聞】政府修例放寬狗隻進入食肆，立法會小組委員會討論時，關注加熱食物的定義和執法問題。政府表示，市民舉報片段難辨真偽，但會作為執法參考，實施初期會每日巡查。 放寬狗隻進入食肆規例將於5月8日生效，基於安全考慮，獲批餐廳不可在餐桌上烹煮或加熱食物，火鍋店和烤肉店更不准申請牌照。多名議員關注火鍋店和加熱的定義。霍啟剛：「有些餐廳不是開宗明義的火鍋店，但餐牌中有這些選擇，亦不是他們主打，如果這些店舖去申請，需要主動在餐單移除你們才容許申請嗎？」管浩鳴：「有些茶餐廳有鐵板餐不是加熱，那些拿上來又計不計，例如石鍋飯，韓式也有。」環境及生態局副秘書長（食物）羅翠薇：「其實在我們牌照條款中，清楚訂明是不容許食肆在任何時段在座位上加熱或烹煮食物，包括明火或電熱爐加熱器具。/如果真的想賣羊肉鍋，就煮好才拿出來，就不可以在桌上烹煮。」 執法方面，有議員關注食環署會否接受市民舉證餐廳違例。何敬康：「是否一定要食環署親身目睹才會作出檢控，在舉證方面透過手機錄影，拍攝到違規情況並提交證據，當局會否接納這一類型的證據。」食環署副署長（環境衞生）姚繼卓：「如果透過影片，懷疑餐廳有違規情況，我們會派出人員到現場進行蒐證，看看現場有沒有違規情況，做一個判斷才會進行執法。」 食環署表示實施初期會派人每日到獲批的食肆巡查，根據現場情況作出提醒，初期會彈性處理，未必即時執法。

monsitj/iStock via Getty Images Despite gold's recent weakness, Wells Fargo analysts said Thursday they remain firmly bullish on the metal in the longer term, forecasting prices to reach $6,100-$6,300/oz by the end of this year, driven by continued central bank demand and an eventual moderation in yields and the U.S. dollar. Wells Fargo expects the Iran war to have a generally limited impact on the economy, with eventual easing inflation pressures and lower Treasury yields later in the year removing key headwinds for bullion, and it expects the conflict to be relatively short-lived, reducing the risk of a sustained inflation increase. The bank also said gold buying at central banks remains well above long-term averages, providing a structural pillar of demand. The analysts recommended investors use the pullback in gold to gradually build positions, suggesting capital could rotate from energy markets into precious metals as the conflict stabilizes. Gold futures resumed their downward momentum Thursday as crude oil prices rebounded, keeping inflation fears intact and ‌sustaining expectations of elevated interest rates, and the U.S. dollar edged higher, making dollar-priced bullion more ​expensive for other currency holders. "Concerns that higher energy prices will push inflation higher, forcing central banks to adopt a more hawkish stance, continue to support the dollar and yields," ADM Investor Services said in a note. Gold and silver both fell for the 10th time in the last 12 sessions on Thursday, with front-month Comex gold ( XAUUSD:CUR ) for March delivery down 3.8% to $4,375.50/oz, its second-lowest settlement of the year, and front-month Comex March silver ( XAGUSD:CUR ) slumping 6.5% to $67.671/oz. ETFs: , ( GDX ), ( GDXJ ), ( IAU ), ( NUGT ), ( PHYS ), ( GLDM ), ( AAAU ), ( SGOL ), ( RING ), ( BAR ), ( OUNZ ), ( SLV ), ( PSLV ), ( SIVR ), ( SIL ), ( SILJ ) More on gold and silver Tarnished Gold Gold Is Speculative Right Now Why I'm Not Waiting Any Longer To Do...

VirTra (VTSI) delivered earnings and revenue surprises of -350.00% and -46.79%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Mariia Vitkovska/iStock via Getty Images BDCs currently occupy a unique niche in the investment community—they provide retail investors with access to private credit markets while distributing the majority of their taxable income as dividends. However, not all companies in the sector are created equal: different portfolios, credit quality, leverage, and risk-premium management can result in different BDCs. In the following, we will examine Gladstone Capital ( GLAD ) in the BDC sector, with a special focus on the benchmark Ares Capital Corporation ( ARCC ). BDC Premium/Discounts Below is shown a chart with the current pricing of all BDCs: BDC Premium/Discounts (author's database) At the time of writing, GLAD is traded at a 17% discount, while the NAV per share of the common stock declined from $21.34 to $21.13 for the last quarter. The benchmark ARCC is at close to a 10.43% discount, and the average BDC is around a 25.4% discount. The discount itself is not an indicator of undervaluation - it often reflects real risk or expectations of deterioration, though in GLAD's case, the metrics suggest the discount may be excessive relative to fundamentals Market Capitalization In the next chart are shown the market capitalizations. We see that GLAD is not among the biggest companies with its close to $407 million market capitalization, and we can't compare it with the biggest, ARCC, and its $13.24 billion market capitalization. The average for the sector is around $1.3 billion. Market Capitalization (author's database) Portfolio Structure and Debt Percentage Per Company Portfolio structure and debt percentage per company (author's database) ARCC and the average BDC are very similar in this comparison, with portfolio debt of approximately 81% and 84%, respectively, whereas GLAD's debt is approximately 95%. 3-Year NAV Total Return The next chart shows the 3-year NAV total return: 3-Year NAV Total Return (author's database) For this metric, GLAD and the average BDC are very clos...

Netflix stock rose Thursday following news that the company once again raised prices for its multiple subscription tiers, another sign for consumers that streaming will continue to get more expensive from here. Netflix updated its plans page on Thursday. “We continue offering a range of prices and plans to meet a variety of needs, and as we deliver more value to our members we are updating our prices to enable us to reinvest in quality entertainment and improve their experience,” a Netflix spokesperson said.

Netflix stock rose Thursday following news that the company once again raised prices for its multiple subscription tiers, another sign for consumers that streaming will continue to get more expensive from here. Netflix updated its plans page on Thursday. “We continue offering a range of prices and plans to meet a variety of needs, and as we deliver more value to our members we are updating our prices to enable us to reinvest in quality entertainment and improve their experience,” a Netflix spokesperson said.

Image source: The Motley Fool. Thursday, March 26, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

David Roman, Goldman Sachs Co-Head of the Health Care Business Unit and Medtech & Health Care IT Analyst, discussed key insights from an inaugural health care conference focused on AI’s impact in the sector. He speaks with Katie Greifeld and Bailey Lipschultz on "The Close." (Source: Bloomberg)

Marvin Samuel Tolentino Pineda Netflix ( NFLX ) is raising the price of all its subscription plans by at least a dollar in a move that was telegraphed during the company’s earnings call in January. “On the revenue side, for 2026, key drivers are similar to ’25. It’s membership growth, its pricing, and it’s a rough doubling of our ad revenue to about $3B,” Netflix CFO Spencer Neumann said on the call. Netflix ( NFLX ) added 23M new subscribers and generated $45.2B in total revenue in 2025. Netflix says it needs the extra money to help pay for the company’s higher content budget, expected to increase by $2B this year to $20B. This includes a slate of live events, including the World Baseball Classic in Japan, podcasts, and a new license deal with Sony ( SONY ). Effective immediately, a standard plan with ads will cost $8.99 a month (+$1), standard with no ads will cost $19.99 a month (+$2), and premium will cost $26.99 a month (+$2). The company also raised its extra member fee by a dollar to $6.99 a month (with ads) and to $9.99 a month (without ads). Netflix ( NFLX ) last raised its subscription fees in January 2025. More on Netflix Netflix: Extended Gains Seem Likely Netflix, Inc. (NFLX) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript Netflix: Moving Along On Its Own Netflix, Warner Music Group to partner on artists documentaries Netflix eyes leveraging KPop Demons success into a world concert tour

A number of stocks fell in the afternoon session as investors reacted to news of Google's new TurboQuant algorithm, a tool that threatens to significantly reduce memory requirements for artificial intelligence models.

Teradyne, Applied Materials, Intel, KLA Corporation, and Semtech Shares Plummet, What You Need To Know Yahoo Finance

Teradyne, Applied Materials, Intel, KLA Corporation, and Semtech Shares Plummet, What You Need To Know finance.yahoo.com

Most software stocks were likely due for a pullback. But this particular stock's decline has arguably gone too far, creating a compelling buying opportunity.